What does BioXcel do?
BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immune-oncology.
Where is BioXcel Therapeutics located?
Overview Suggest Edit
| Type | Public |
|---|---|
| Founded | 2017 |
| HQ | New Haven, CT, US |
| Website | bioxceltherapeutics.com |
What is BXCL701?
BXCL701 is an investigational orally administered innate immune activator designed to initiate inflammation in the tumor microenvironment. Approved and experimental immunotherapies often struggle to address cancers that appear “cold” or uninflamed.
What did bioxcel Corporation announce?
BRANFORD, Conn., Jan 11, 2016 — BioXcel Corporation, a global leader in developing cloud-based big data platforms and transformative patient treatments, today announced a strategic big data collaboration with Centrexion Therapeutics to develop a portfolio of clinical pain therapeutic assets.
Why bioxcel for Neuroscience?
Improving the Quality of Life (QoL) of patients with Neurological Disorders. BioXcel’s Neuroscience programs are focused on discovering and developing therapeutics for neurological disorders with high unmet medical need.
How is bioxcel using big data in drug discovery?
Branford, Conn.,-based Bioxcel Corp. is working with industry partners to help improve upon its decision-making in drug discovery. The firm has developed a cloud-based big-data analytics platform, known as PharmGPS a disease area-focused, analytics engine encompassing all major and specialty therapeutic areas.
What is bioxcel doing with Takeda?
BioXcel said today it has joined with Takeda Pharmaceutical’s U.S.-based global development group to repurpose compounds into new treatments for rare diseases. The value of the partnership was not disclosed. BioXcel said the expertise of its Big Data Innovation Lab will be tapped in its new partnership with Takeda Development Center Americas.